With the release of the Company Report for 2020, N4 Pharma’s CEO, Nigel Theobald, has spoken to Directors Talk about the highlights of last year year. He provides an update on our new refined strategy to focus on three work streams and explains what the Patent in relation to Nuvec® means for the company. Watch the interview in full below or read the article.
